Drug Chatter -- Tracking biopharma stock chatter

Profile for Alimera Sciences, Inc. (ALIM)

« Back to company index

ALIM Chatter Timeline

Stock Ticker for ALIM

Most Active Tweeters for ALIM

UserTweets
@COCKRELLGROUP 4
@VisualStockRSRC 2
@storminvestor 2
@Allstocknews 2
@SPNewsAnalysis 2

Recent Tweets for ALIM

SPNewsAnalysis @SPNewsAnalysis
Alimera Sciences, Inc. $ALIM Given Average Recommendation of “Strong Buy” by Brokerages https://t.co/pheYj6kzVe
November 17th 2017, 6:11pm
storminvestor @storminvestor
Alimera Sciences, Inc. $ALIM Given Average Recommendation of “Strong Buy” by Brokerages https://t.co/nWHQJ0lcyp
November 17th 2017, 6:11pm
wosaikeneriki @wosaikeneriki
Alimera Sciences $ALIM Shareholder Deerfield Management Company Has Cut Stake as Stock Value Rose ...
November 16th 2017, 4:11pm
TranscriptDaily @TranscriptDaily
Head to Head Review: Onconova Therapeutics $ONTX & Alimera Sciences $ALIM https://t.co/5k75Dei08e
November 16th 2017, 3:11am
ConsumerFeed @ConsumerFeed
Head to Head Review: Onconova Therapeutics $ONTX & Alimera Sciences $ALIM https://t.co/JhYaKRPvR9 #acn
November 16th 2017, 3:11am
CFinancialNews @CFinancialNews
Head to Head Review: Onconova Therapeutics $ONTX & Alimera Sciences $ALIM https://t.co/xcT8zDyfSg
November 16th 2017, 3:11am
intercooleronli @intercooleronli
Head to Head Review: Onconova Therapeutics $ONTX & Alimera Sciences $ALIM https://t.co/9zWhKJUKE6
November 16th 2017, 3:11am
AmericanBanking @AmericanBanking
Head to Head Review: Onconova Therapeutics $ONTX & Alimera Sciences $ALIM https://t.co/zTiJdtAhWk
November 16th 2017, 3:11am
stocknewstimes @stocknewstimes
Alimera Sciences, Inc. $ALIM Given “Buy” Rating at HC Wainwright https://t.co/RndBd2s12X
November 15th 2017, 8:11pm
SleekMoneycom @SleekMoneycom
Alimera Sciences, Inc. $ALIM Given “Buy” Rating at HC Wainwright https://t.co/k0SiQD9Pu9
November 15th 2017, 8:11pm
AmericanBanking @AmericanBanking
Alimera Sciences Gets Average Rating of Hold from Analysts $ALIM https://t.co/rmFRCZnOKO
November 15th 2017, 11:11am
dispatchtribune @dispatchtribune
Alimera Sciences, Inc. $ALIM Receives “Buy” Rating from Cowen and Company https://t.co/3WO9Nt1TKe
November 15th 2017, 7:11am
WeekHerald @WeekHerald
Alimera Sciences, Inc. $ALIM Given “Buy” Rating at Cowen and Company https://t.co/lsyD6cVnBV
November 15th 2017, 12:11am
ConsumerFeed @ConsumerFeed
Zacks: Alimera Sciences, Inc. $ALIM Given Average Recommendation of “Strong Buy” by Brokerages https://t.co/4H9B8tNSCx #acn
November 14th 2017, 1:11pm
intercooleronli @intercooleronli
Zacks: Alimera Sciences, Inc. $ALIM Given Average Recommendation of “Strong Buy” by Brokerages https://t.co/75pVcz8PYe
November 14th 2017, 1:11pm
dispatchtribune @dispatchtribune
Alimera Sciences $ALIM Receiving Somewhat Positive Media Coverage, Study Finds https://t.co/0lUrdABt7n
November 14th 2017, 8:11am
ledgerzette @ledgerzette
Alimera Sciences, Inc. $ALIM Receives Buy Rating from HC Wainwright https://t.co/TkzV34ehoP
November 13th 2017, 9:11am
WeekHerald @WeekHerald
HC Wainwright Reiterates Buy Rating for Alimera Sciences, Inc. $ALIM https://t.co/RGjWY2nSDY
November 12th 2017, 3:11am
COCKRELLGROUP @COCKRELLGROUP
Alimera Sciences $ALIM Announces Nine iluvien® data sets to be Presented at 2017 american academy of ophthalmology https://t.co/4fs64chy7g
November 9th 2017, 9:11am
SleekMoneycom @SleekMoneycom
Head to Head Review: Alimera Sciences $ALIM vs. Its Competitors https://t.co/ylFlOr6Fup
November 9th 2017, 1:11am
SPNewsAnalysis @SPNewsAnalysis
Analyzing Alimera Sciences $ALIM & Its Competitors https://t.co/CpkQdcHSrx
November 8th 2017, 4:11pm
storminvestor @storminvestor
Analyzing Alimera Sciences $ALIM & Its Competitors https://t.co/9vlLtWAyhx
November 8th 2017, 4:11pm
CRWECrownEquity @CRWECrownEquity
$ALIM to reveal findings from studies evaluating ILUVIEN for diabetic macular edema https://t.co/86pLr2zAgu
November 8th 2017, 2:11pm
StockNewsNow @StockNewsNow
$ALIM Alimera Sciences Announces Nine iluvien® data sets to be Presented at 2017 american academy of ophthalmology https://t.co/ByMbQbbU0g
November 8th 2017, 9:11am
COCKRELLGROUP @COCKRELLGROUP
Alimera Sciences $ALIM Announces 9 iluvien® data sets to be Presented at 2017 american academy of ophthalmology https://t.co/y8gO53OWSM
November 8th 2017, 8:11am
Allstocknews @Allstocknews
$ALIM Alimera Sciences Announces Nine iluvien® data sets to be Presented at 2017 american academy of ophthalm From our Stock News Alerts App
November 8th 2017, 7:11am
stockboardinc @stockboardinc
$ALIM Alimera Sciences Announces Nine iluvien® data sets to be Presented at 2017 american academy of opht... - https://t.co/8oRiOjAwVq
November 8th 2017, 7:11am
VisualStockRSRC @VisualStockRSRC
$ALIM - Alimera Sciences Announces Nine iluvien® data sets to be Presented at 2017 american academy of https://t.co/jWzP2rgH3j
November 8th 2017, 7:11am
GNWLive @GNWLive
Alimera Sciences Announces Nine iluvien® data sets to be Presented at 2017 american academy of $ALIM https://t.co/wBDEuosjgi
November 8th 2017, 7:11am
BidOutLoud @BidOutLoud
$ALIM Buying all the way down waiting for Monte Carlo.
November 7th 2017, 10:11am
COCKRELLGROUP @COCKRELLGROUP
Edited Transcript of $ALIM earnings conference call or presentation 2-Nov-17 1:00pm GMT https://t.co/yYOabn56Av
November 7th 2017, 9:11am
COCKRELLGROUP @COCKRELLGROUP
$ALIM CEO Dan Myers to Present During Ophthalmology Innovation Summit AAO 2017 New Orleans Nov 9, 3:35-4:45 pm https://t.co/E3rtrWicDy
November 7th 2017, 9:11am
StockNewsNow @StockNewsNow
$ALIM Alimera Sciences' CEO Dan Myers to Present During Ophthalmology Innovation Summit at American Academy of... https://t.co/gLuOLaZ1vH
November 7th 2017, 8:11am
stockboardinc @stockboardinc
$ALIM Alimera Sciences' CEO Dan Myers to Present During Ophthalmology Innovation Summit at American Academ... - https://t.co/MKnxIQs2pQ
November 7th 2017, 7:11am
Allstocknews @Allstocknews
$ALIM Alimera Sciences' CEO Dan Myers to Present During Ophthalmology Innovation Summit at American Academy o From our Stock News Alerts App
November 7th 2017, 7:11am
VisualStockRSRC @VisualStockRSRC
$ALIM - Alimera Sciences' CEO Dan Myers to Present During Ophthalmology Innovation Summit at American Academy https://t.co/zaOIpKoQZC
November 7th 2017, 7:11am
GNWLive @GNWLive
Alimera Sciences' CEO Dan Myers to Present During Ophthalmology Innovation Summit at American Academy of $ALIM https://t.co/cDl1bUY0CF
November 7th 2017, 7:11am
WatchlistN @WatchlistN
Alimera Sciences $ALIM Given Media Impact Score of 0.17 https://t.co/carFRkUGJq
November 7th 2017, 12:11am
wlstcom @wlstcom
Edited Transcript of ALIM earnings conference call or presentation 2-Nov-17 1:00pm GMT $ALIM https://t.co/S6DviHMrfm https://t.co/diTKbPj8zR
November 6th 2017, 9:11am
COCKRELLGROUP @COCKRELLGROUP
Edited Transcript of Alimera Sciences $ALIM earnings conference call or presentation 2-Nov-17 1:00pm GMT https://t.co/yYOabn56Av
November 6th 2017, 9:11am
dispatchtribune @dispatchtribune
Alimera Sciences’ $ALIM “Buy” Rating Reiterated at Cowen and Company https://t.co/qLZjrimxf1
November 6th 2017, 7:11am
confcalltran @confcalltran
Alimera Sciences Just Filed Its Quarterly Report: LOSS PER SHARE (EPS)... https://t.co/GmVFQz688T $ALIM
November 6th 2017, 7:11am
Allstocknews @Allstocknews
$ALIM New Form EFFECT for Alimera Sciences, Inc. From our Stock News Alerts App
November 6th 2017, 6:11am
confcalltran @confcalltran
Alimera Sciences Just Received a Notice of Effectiveness https://t.co/ORVYmxLI9g $ALIM
November 6th 2017, 6:11am
StockTexts @StockTexts
$ALIM Alimera Sciences, Inc. SEC Filing: Form EFFECT https://t.co/Foll7qtexs
November 6th 2017, 6:11am
VisualStockRSRC @VisualStockRSRC
$ALIM - Notice of Effectiveness (effect) https://t.co/UHIkt9GPYN
November 6th 2017, 6:11am
chaffeybreeze @chaffeybreeze
Alimera Sciences $ALIM vs. The Competition Head to Head Analysis https://t.co/inRXUC3nEB
November 6th 2017, 5:11am
IRAMarketReport @IRAMarketReport
Alimera Sciences $ALIM vs. The Competition Head to Head Analysis https://t.co/hPcjOSv1XV
November 6th 2017, 4:11am
ZolmaxNews @ZolmaxNews
Alimera Sciences’ $ALIM “Buy” Rating Reiterated at Cowen and Company https://t.co/UrSFBWOCK3
November 6th 2017, 12:11am
ZolmaxNews @ZolmaxNews
$ALIM - Alimera Sciences' #ALIM "Buy" Rating Reiterated at Cowen and Company https://t.co/wAr2tVHWLY
November 6th 2017, 12:11am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.